Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide Receptors”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Not applicableUnknownNCT05268627
What this trial is testing

Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss

Who this might be right for
Obesity
Mansoura University 38
Not applicableLooking for participantsNCT07743567
What this trial is testing

Gestational Response, Outcomes, and Weight After GLP-1 Use

Who this might be right for
Pregnant IndividualsObesity & OverweightGestational Weight Gain
University of Kansas Medical Center 400
Not applicableNot Yet RecruitingNCT07700030
What this trial is testing

High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)

Who this might be right for
Weight Loss
NYU Langone Health 32
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Large-scale testing (Phase 3)Looking for participantsNCT07282041
What this trial is testing

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Who this might be right for
Intracranial AtherosclerosisStroke, Ischemic
National University of Singapore 130
Not applicableUnknownNCT05492305
What this trial is testing

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Who this might be right for
Diabetes MellitusObesityMental Health Issue
King's College London 20
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Post-approval studies (Phase 4)Study completedNCT02276196
What this trial is testing

Effect of LIXIsenatide on the Renal System

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes Mellitus+1 more
Amsterdam UMC, location VUmc 40
Not applicableLooking for participantsNCT07065383
What this trial is testing

Rebalancing the Fat Content of the Heart and Muscles

Who this might be right for
Diabetes Mellitus Type 2
University of Aberdeen 60
Early research (Phase 1)Study completedNCT01304823
What this trial is testing

Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY

Who this might be right for
Taste Disorder, Primary, Sweet
University Hospital, Basel, Switzerland 10
Early research (Phase 1)Not Yet RecruitingNCT07842393
What this trial is testing

IBI3042 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers (HV)
Fortvita Biologics (USA)Inc. 32
Early research (Phase 1)Study completedNCT01088841
What this trial is testing

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Who this might be right for
Appetite and General Nutritional DisordersHormone Replacement
University Hospital, Basel, Switzerland 16
Not applicableLooking for participantsNCT07091500
What this trial is testing

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity

Who this might be right for
ObesitySkeletal MuscleBrain Connectivity
Washington University School of Medicine 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06788626
What this trial is testing

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

Who this might be right for
Acute Ischemic StrokeLarge Vessel OcclusionNeuroprotective Drugs+1 more
Wei Hu 390
Post-approval studies (Phase 4)Study completedNCT05218915
What this trial is testing

Basal Plus GLP1-ra on Glycemic Variability in CKD

Who this might be right for
Diabetes MellitusDiabetic Kidney Disease
Elaine Chow 95
Early research (Phase 1)Active Not RecruitingNCT05202353
What this trial is testing

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

Who this might be right for
Obesity
Boehringer Ingelheim 29
Post-approval studies (Phase 4)Study completedNCT02686177
What this trial is testing

Effect of GLP-1 on Angiogenesis

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 50
Post-approval studies (Phase 4)Study completedNCT04881110
What this trial is testing

Liraglutide and Peripheral Artery Disease

Who this might be right for
Type 2 DiabetesPeripheral Arterial Disease
University of Campania Luigi Vanvitelli 60
Next Page